343 related articles for article (PubMed ID: 24161279)
1. Modeling nigrostriatal degeneration in organotypic cultures, a new ex vivo model of Parkinson's disease.
Daviaud N; Garbayo E; Lautram N; Franconi F; Lemaire L; Perez-Pinzon M; Montero-Menei CN
Neuroscience; 2014 Jan; 256():10-22. PubMed ID: 24161279
[TBL] [Abstract][Full Text] [Related]
2. ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.
Salvatore MF
J Neurochem; 2014 May; 129(3):548-58. PubMed ID: 24410633
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
[TBL] [Abstract][Full Text] [Related]
4. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
Nordströma U; Beauvais G; Ghosh A; Pulikkaparambil Sasidharan BC; Lundblad M; Fuchs J; Joshi RL; Lipton JW; Roholt A; Medicetty S; Feinstein TN; Steiner JA; Escobar Galvis ML; Prochiantz A; Brundin P
Neurobiol Dis; 2015 Jan; 73():70-82. PubMed ID: 25281317
[TBL] [Abstract][Full Text] [Related]
5. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
[TBL] [Abstract][Full Text] [Related]
6. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
[TBL] [Abstract][Full Text] [Related]
7. The effects of nigrostriatal dopamine depletion on the thalamic parafascicular nucleus.
Kusnoor SV; Bubser M; Deutch AY
Brain Res; 2012 Mar; 1446():46-55. PubMed ID: 22353754
[TBL] [Abstract][Full Text] [Related]
8. Characterization of graded 6-Hydroxydopamine unilateral lesion in medial forebrain bundle of mice.
Cui J; Zhao D; Xu M; Li Z; Qian J; Song N; Wang J; Xie J
Sci Rep; 2024 Feb; 14(1):3721. PubMed ID: 38355892
[TBL] [Abstract][Full Text] [Related]
9. Rat brain sagittal organotypic slice cultures as an ex vivo dopamine cell loss system.
McCaughey-Chapman A; Connor B
J Neurosci Methods; 2017 Feb; 277():83-87. PubMed ID: 28012853
[TBL] [Abstract][Full Text] [Related]
10. Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat.
Hutson CB; Lazo CR; Mortazavi F; Giza CC; Hovda D; Chesselet MF
J Neurotrauma; 2011 Sep; 28(9):1783-801. PubMed ID: 21644813
[TBL] [Abstract][Full Text] [Related]
11. Altered melatonin MT
Kang NH; Carriere CH; Bahna SG; Niles LP
Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
[TBL] [Abstract][Full Text] [Related]
12. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237
[TBL] [Abstract][Full Text] [Related]
13. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric dopaminergic degeneration and levodopa alter functional corticostriatal connectivity bilaterally in experimental parkinsonism.
Monnot C; Zhang X; Nikkhou-Aski S; Damberg P; Svenningsson P
Exp Neurol; 2017 Jun; 292():11-20. PubMed ID: 28223037
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
[TBL] [Abstract][Full Text] [Related]
16. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
17. Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract.
Van Camp N; Blockx I; Verhoye M; Casteels C; Coun F; Leemans A; Sijbers J; Baekelandt V; Van Laere K; Van der Linden A
NMR Biomed; 2009 Aug; 22(7):697-706. PubMed ID: 19378292
[TBL] [Abstract][Full Text] [Related]
18. Time course study of fractional anisotropy in the substantia nigra of a parkinsonian rat model induced by 6-OHDA.
Zhang W; Zhang L; Liu L; Wang X
Behav Brain Res; 2017 Jun; 328():130-137. PubMed ID: 28390876
[TBL] [Abstract][Full Text] [Related]
19. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
[TBL] [Abstract][Full Text] [Related]
20. Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease.
Zhang Y; Wu IW; Buckley S; Coffey CS; Foster E; Mendick S; Seibyl J; Schuff N
Mov Disord; 2015 Aug; 30(9):1229-36. PubMed ID: 25920732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
